Facebook Gastroesophageal Cancer Drug: The Evolving Landscape from Chemotherapy to Immuno-Targeted Combination Regimens – 10.4% CAGR Driven by Precision Medicine
Logo

Gastroesophageal Cancer Drug: The Evolving Landscape from Chemotherapy to Immuno-Targeted Combination Regimens – 10.4% CAGR Driven by Precision Medicine

クレジット
Avatar
イラストレーター
Gastroesophageal Cancer Drug: The Evolving Landscape from Chemotherapy to Immuno-Targeted Combination Regimens – 10.4% CAGR Driven by Precision Medicine-1
シェア
Ciciの他の作品